Traws Pharma
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $57 | $57 | $56 | $56 |
Gross Profit | 57 | 53 | 52 | 52 |
EBITDA | -8,534 | -5,880 | -5,208 | -4,458 |
EBIT | -8,536 | -5,884 | -5,212 | -4,462 |
Net Income | -8,475 | -123,143 | -4,983 | -4,184 |
Net Change In Cash | 57 | 57 | 56 | 56 |
Free Cash Flow | -11,476 | -9,852 | -4,424 | -4,430 |
Cash | 5,410 | 16,886 | 16,390 | 20,821 |
Basic Shares | 961 | 25,310 | 21,043 | 21,003 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $226 | $226 | $226 | $231 |
Gross Profit | 210 | 212 | 212 | 231 |
EBITDA | -20,282 | -19,613 | -16,482 | -24,980 |
EBIT | -20,298 | -19,627 | -16,496 | -24,993 |
Net Income | -18,948 | -18,964 | -16,163 | -25,157 |
Net Change In Cash | 226 | 226 | 226 | 231 |
Free Cash Flow | -17,946 | -16,294 | -19,487 | -23,090 |
Cash | 20,821 | 38,757 | 55,070 | 19,025 |
Basic Shares | 20,988 | 20,908 | 16,832 | 11,602 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$8.81 |
2024-06-30 | -$4.86 |
2024-03-31 | -$0.19 |
2023-12-31 | -$0.19 |
